Wentao Wu

Chief Operating Officer at Xynomic Pharmaceuticals, Inc.

56 year

Health Technology

Consumer Services

Profile

Wentao Wu is currently the Chief Operating Officer at Xynomic Pharmaceuticals, Inc. She previously worked as the Director of Business Development at Hutchison MediPharma Ltd.
from 2002 to 2004, and as the Head of Research and Development at American Oriental Bioengineering, Inc. from 2004 to 2009.
She also served as the Chief Operating Officer at Xynomic Pharmaceuticals Holdings, Inc. Dr. Wu holds a Master's in Business Administration from Indiana University and a doctorate from Purdue University.

Wentao Wu active positions

Companies	Position	Start
Xynomic Pharmaceuticals, Inc. Xynomic Pharmaceuticals, Inc. BiotechnologyHealth Technology Xynomic Pharmaceuticals, Inc. operates as biopharmaceutical company. It develops and commercializes innovative oncology drugs to address unmet medical needs in solid tumor and hematological malignancies and to improve cancer patients’ life expectancy and treatment prognosis. The company was founded by Yinglin Mark Xu in 2016 and is headquartered in Dover, DE.	Chief Operating Officer	-

All active positions of Wentao Wu

Former positions of Wentao Wu

Companies	Position	End
AMERICAN ORIENTAL BIOENGINEERING, INC.	Chief Tech/Sci/R&D Officer	2008-12-31
Hutchison MediPharma Ltd. Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China.	Corporate Officer/Principal	2003-12-31
XYNOMIC PHARMACEUTICALS HOLDINGS, INC.	Chief Operating Officer	-

See the detail of Wentao Wu's experience

Training of Wentao Wu

Indiana University	Masters Business Admin
Purdue University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Wentao Wu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
AMERICAN ORIENTAL BIOENGINEERING, INC.	Health Technology

Private companies	3
Hutchison MediPharma Ltd. Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China.	Health Technology
Xynomic Pharmaceuticals, Inc. Xynomic Pharmaceuticals, Inc. BiotechnologyHealth Technology Xynomic Pharmaceuticals, Inc. operates as biopharmaceutical company. It develops and commercializes innovative oncology drugs to address unmet medical needs in solid tumor and hematological malignancies and to improve cancer patients’ life expectancy and treatment prognosis. The company was founded by Yinglin Mark Xu in 2016 and is headquartered in Dover, DE.	Health Technology
Xynomic Pharmaceuticals Holdings, Inc. Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China.	Health Technology

See company connections